Depression News and Research

Latest Depression News and Research

Pimple Clinic program donates acne products to low-income families

The Pimple Clinic, a safe, effective non-prescription line of acne products developed by the dermatologist who founded Skinstore.com, is being provided to low-income teens that otherwise cannot afford acne treatments.

17 Mar 2010

Antidepressants effective against depression in patients suffering from physical illnesses

Antidepressants are effective against depression in patients suffering from physical illnesses, according to a new systematic review by Cochrane researchers at King's Health Partners Academic Health Sciences Centre in the UK. The researchers found the drugs were more effective than placebos at treating depression in these patients.

17 Mar 2010

HealthInsight provides HealthMedia online Digital Coaching solution to Sutter Physician Services

HealthInsight, provider of the leading value-based health care administration platform, today announced the company is providing the HealthMedia®online Digital Coaching solution to Sutter Physician Services for their new Wellness 2010 program. The combination of HealthInsight’s value-based compliance tracking and HealthMedia’s online Digital Coaching solution will help Sutter dramatically reduce their health care costs while improving their employees’ health.

15 Mar 2010

Verisk Health upgrades Explorer product line to improve organization’s exposure to healthcare risk

Verisk Health, Inc., a global leader in healthcare data analytics and risk management, today announced several upgrades to its Explorer product line, including functionality that allows users to evaluate the impact of a member’s lifestyle behaviors on an organization’s overall healthcare and utilization costs.

12 Mar 2010

Arena Pharmaceuticals reports lower net loss allocable to common stockholders in fourth-quarter 2009

Arena Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2009.

12 Mar 2010

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat- (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

12 Mar 2010

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.

12 Mar 2010

Azur Pharma to acquire PRIALT analgesic therapy from Elan Pharmaceuticals

Azur Pharma Limited today announced it has signed a definitive agreement with Elan Pharmaceuticals, Inc. (a subsidiary of Elan Corporation, plc) to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion).

12 Mar 2010

Survey: Employers plan to shift more health costs to workers

The Washington Post: "Most big employers plan to shift a larger share of health-care costs to their workers next year, according to a survey to be released Thursday. ... Meanwhile, employees at many companies can expect significantly higher premiums, deductibles and co-payments, according to the annual survey by the National Business Group on Health, a coalition of big employers, and Towers Watson, a consulting firm that advises companies on employee benefits."

12 Mar 2010

Study explores incidence of eating disorders among type 1 diabetic patients

Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said.

12 Mar 2010

New insurance plan to link a patient's cost to effectiveness of treatments

Kaiser Health News staff writer Julie Appleby, working in collaboration with USA Today, writes about potentially controversial policies that are a trend toward value-based design.

11 Mar 2010

First Edition: March 11, 2010

Today's headlines offer details of President Obama's continued full-court press on health reform with an appearance in Missouri. Meanwhile, work to move the bill toward a vote continues on Capitol Hill.

11 Mar 2010

Two different ways of remembering things initiated by entirely different signal paths in brain: Study

Entirely different signal paths and parts of the brain are involved when you try to remember something and when you just happen to remember something, prompted by a smell, a picture, or a word, for instance. This is shown by Kristiina Kompus in her dissertation at Umeå University in Sweden.

11 Mar 2010

Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression

Evotec AG today announced two positive aspects that strengthen its integrated product development in treatment-resistant depression in its strategic alliance with Roche.

11 Mar 2010

Evotec, Active Biotech announce collaboration to identify small molecule modulators of priority biological target

Evotec AG today announced that it has entered into a collaboration with Active Biotech AB to identify small molecule modulators of a priority biological target, selected by Active Biotech, involved in immune disorders and cancer.

11 Mar 2010

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.

11 Mar 2010

Childhood bad behaviour linked to chronic widespread pain in adult life

Bad behaviour in childhood is associated with long-term, chronic widespread pain in adult life, according to the findings of a study following nearly 20,000 people from birth in 1958 to the present day.

10 Mar 2010

Relaxation therapy as effective as massage therapy

A new randomized trial shows that on average, three months after receiving a series of 10 massage sessions, patients had half the symptoms of anxiety.

10 Mar 2010

MIT researchers to use Elekta Neuromag system to study neural basis of brain disorders

Researchers at MIT are eagerly anticipating the summer delivery of Elekta Neuromag®, a system that uses magnetoencephalography or MEG to explore brain function. MEG can detect the very weak magnetic fields arising from electrical activity in the brain, and allows researchers to monitor the timing of brain activity with millisecond precision.

From Elekta 10 Mar 2010

Activity in lateral prefrontal cortex may improve emotion regulation in day-to-day life

Common wisdom tells us that for a successful relationship partners shouldn't go to bed angry. But new research from a psychologist at Harvard University suggests that brain activity-specifically in the region called the lateral prefrontal cortex-is a far better indicator of how someone will feel in the days following a fight with his or her partner.

9 Mar 2010

Depression News and Research

Latest Depression News and Research

Pimple Clinic program donates acne products to low-income families

Antidepressants effective against depression in patients suffering from physical illnesses

HealthInsight provides HealthMedia online Digital Coaching solution to Sutter Physician Services

Verisk Health upgrades Explorer product line to improve organization’s exposure to healthcare risk

Arena Pharmaceuticals reports lower net loss allocable to common stockholders in fourth-quarter 2009

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

Azur Pharma to acquire PRIALT analgesic therapy from Elan Pharmaceuticals

Survey: Employers plan to shift more health costs to workers

Study explores incidence of eating disorders among type 1 diabetic patients

New insurance plan to link a patient's cost to effectiveness of treatments

First Edition: March 11, 2010

Two different ways of remembering things initiated by entirely different signal paths in brain: Study

Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression

Evotec, Active Biotech announce collaboration to identify small molecule modulators of priority biological target

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

Childhood bad behaviour linked to chronic widespread pain in adult life

Relaxation therapy as effective as massage therapy

MIT researchers to use Elekta Neuromag system to study neural basis of brain disorders

Activity in lateral prefrontal cortex may improve emotion regulation in day-to-day life

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in